Lyra Therapeutics (LYRA) Earnings Date & Reports

A.I. Advisor

published Earnings

LYRA is expected to report earnings to fall 58.69% to -30 cents per share on November 05

Lyra Therapeutics LYRA Stock Earnings Reports

Q3'24

Est.

$-0.31

Q2'24

Missed

by $0.41

Q1'24

Missed

by $0.09

Q4'23

Beat

by $0.13

Q3'23

Beat

by $0.05

The last earnings report on August 14 showed earnings per share of -74 cents, missing the estimate of -33 cents. With 1.08M shares outstanding, the current market capitalization sits at 17.39M.

View a ticker or compare two or three

Compare

LYRA

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For LYRA
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a clinical-stage therapeutics company, which develops novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose and throat, or ENT, diseases

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

480 Arsenal Way

Phone

+1 617 393-4600

Employees

145

Web

https://lyratherapeutics.com